Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
Top Cited Papers
Open Access
- 14 November 2018
- Vol. 363, k4365
- https://doi.org/10.1136/bmj.k4365
Abstract
Objective To assess the association between the use of sodium glucose cotransporter 2 (SGLT2) inhibitors and seven serious adverse events of current concern. Design Register based cohort study. Setting Sweden and Denmark from July 2013 to December 2016. Participants A propensity score matched cohort of 17 213 new users of SGLT2 inhibitors (dapagliflozin, 61%; empagliflozin, 38%; canagliflozin, 1%) and 17 213 new users of the active comparator, glucagon-like peptide 1 (GLP1) receptor agonists. Main outcome measures The primary outcomes were lower limb amputation, bone fracture, diabetic ketoacidosis, acute kidney injury, serious urinary tract infection, venous thromboembolism, and acute pancreatitis, as identified from hospital records. Hazard ratios and 95% confidence intervals were estimated by using Cox proportional hazards models. Results Use of SGLT2 inhibitors, as compared with GLP1 receptor agonists, was associated with an increased risk of lower limb amputation (incidence rate 2.7 v 1.1 events per 1000 person years, hazard ratio 2.32, 95% confidence interval 1.37 to 3.91) and diabetic ketoacidosis (1.3 v 0.6, 2.14, 1.01 to 4.52) but not with bone fracture (15.4 v 13.9, 1.11, 0.93 to 1.33), acute kidney injury (2.3 v 3.2, 0.69, 0.45 to 1.05), serious urinary tract infection (5.4 v 6.0, 0.89, 0.67 to 1.19), venous thromboembolism (4.2 v 4.1, 0.99, 0.71 to 1.38) or acute pancreatitis (1.3 v 1.2, 1.16, 0.64 to 2.12). Conclusions In this analysis of nationwide registers from two countries, use of SGLT2 inhibitors, as compared with GLP1 receptor agonists, was associated with an increased risk of lower limb amputation and diabetic ketoacidosis, but not with other serious adverse events of current concern.Keywords
This publication has 43 references indexed in Scilit:
- Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trialsBone, 2014
- Performance and Limitations of Administrative Data in the Identification of AKIClinical Journal of the American Society of Nephrology, 2014
- Genital and urinary tract infections in diabetes: Impact of pharmacologically-induced glucosuriaDiabetes Research and Clinical Practice, 2014
- Amputations and foot ulcers in patients newly diagnosed with Type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co‐morbidityDiabetic Medicine, 2013
- One‐to‐many propensity score matching in cohort studiesPharmacoepidemiology and Drug Safety, 2012
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Some Methods of Propensity‐Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulationsBiometrical Journal, 2009
- Multiple imputation: review of theory, implementation and softwareStatistics in Medicine, 2007
- Estimating and Using Propensity Scores with Partially Missing DataJournal of the American Statistical Association, 2000
- Estimating and Using Propensity Scores with Partially Missing DataJournal of the American Statistical Association, 2000